Author:
Prabhu Malavika,Eckert Linda O.
Subject
Infectious Diseases,Virology
Reference11 articles.
1. World Health Organization. Guidelines to assure the quality, safety and efficacy of recombinant human papillomavirus-like particle vaccines. WHO Technical Report Series, Annex 1. 〈http://whqlibdoc.who.int/trs/WHO_TRS_962_eng.pdf?Ua=1〉, 2006 (accessed 15.05.15).
2. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study;de Sanjose;Lancet Oncol.,2010
3. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials;Future;Lancet,2007
4. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women;Paavonen;Lancet,2009
5. Human papillomavirus vaccines WHO position paper;World Health Organization;WHO Wkly. Epidemiol. Rec.,2009
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献